158 related articles for article (PubMed ID: 2876723)
21. The effect of topical sodium cromoglycate on intranasal histamine challenge in allergic rhinitis.
Birchall MA; Henderson JC; Studham JM; Pride NB; Fuller RW
Clin Otolaryngol Allied Sci; 1994 Dec; 19(6):521-5. PubMed ID: 7895384
[TBL] [Abstract][Full Text] [Related]
22. Levocabastine. An update of its pharmacology, clinical efficacy and tolerability in the topical treatment of allergic rhinitis and conjunctivitis.
Noble S; McTavish D
Drugs; 1995 Dec; 50(6):1032-49. PubMed ID: 8612470
[TBL] [Abstract][Full Text] [Related]
23. Topical levocabastine is more effective than sodium cromoglycate for the prophylaxis and treatment of seasonal allergic conjunctivitis.
Davies BH; Mullins J
Allergy; 1993 Oct; 48(7):519-24. PubMed ID: 7902022
[TBL] [Abstract][Full Text] [Related]
24. Topical levocabastine versus sodium cromoglycate in allergic conjunctivitis.
Odelram H; Björkstén B; af Klercker T; Rimås M; Kjellman NI; Blychert LO
Allergy; 1989 Aug; 44(6):432-6. PubMed ID: 2572181
[TBL] [Abstract][Full Text] [Related]
25. The effect of intranasal azelastine, Rhinolast, on nasal airways obstruction and sneezing following provocation testing with histamine and allergen.
Thomas KE; Ollier S; Ferguson H; Davies RJ
Clin Exp Allergy; 1992 Jun; 22(6):642-7. PubMed ID: 1393763
[TBL] [Abstract][Full Text] [Related]
26. Double-blind comparison of levocabastine eye drops with sodium cromoglycate and placebo in the treatment of seasonal allergic conjunctivitis.
Azevedo M; Castel-Branco MG; Oliveira JF; Ramos E; Delgado L; Almeida J
Clin Exp Allergy; 1991 Nov; 21(6):689-94. PubMed ID: 1685691
[TBL] [Abstract][Full Text] [Related]
27. Onset and duration of action of levocabastine nasal spray in atopic patients under nasal challenge conditions.
Corren J; Rachelefsky G; Spector S; Schanker H; Siegel S; Holton D; Karcher K; Travers S
J Allergy Clin Immunol; 1999 Apr; 103(4):574-80. PubMed ID: 10200003
[TBL] [Abstract][Full Text] [Related]
28. Effect of terfenadine and budesonide on nasal symptoms, olfaction, and nasal airway patency following allergen challenge.
Hilberg O
Allergy; 1995 Aug; 50(8):683-8. PubMed ID: 7503405
[TBL] [Abstract][Full Text] [Related]
29. The effects of disodium cromoglycate and beclomethasone dipropionate on the immediate response of the nasal mucosa to allergen challenge.
Pelikan Z; Pelikan-Filipek M
Ann Allergy; 1982 Nov; 49(5):283-92. PubMed ID: 6816103
[TBL] [Abstract][Full Text] [Related]
30. Effect of topical levocabastine on allergic and non-allergic perennial rhinitis. A double-blind study, levocabastine vs. placebo, followed by an open, prospective, single-blind study on beclomethasone.
van de Heyning PH; van Haesendonck J; Creten W; Rombaut N
Allergy; 1988 Jul; 43(5):386-91. PubMed ID: 3046408
[TBL] [Abstract][Full Text] [Related]
31. Levocabastine: an effective topical treatment of allergic rhinoconjunctivitis.
Janssens MM; Vanden Bussche G
Clin Exp Allergy; 1991 May; 21 Suppl 2():29-36. PubMed ID: 1680536
[TBL] [Abstract][Full Text] [Related]
32. The effect of levocabastine and furosemide pretreatment on hyperreactive response after nasal provocation with hypotonic aerosol in subjects with allergic rhinitis.
Anzic SA; Dzepina D; Kalogjera L
Eur Arch Otorhinolaryngol; 2007 Nov; 264(11):1309-14. PubMed ID: 17618447
[TBL] [Abstract][Full Text] [Related]
33. Comparison of five new antihistamines (H1-receptor antagonists) in patients with allergic rhinitis using nasal provocation studies and skin tests.
van Steekelenburg J; Clement PA; Beel MH
Allergy; 2002 Apr; 57(4):346-50. PubMed ID: 11906367
[TBL] [Abstract][Full Text] [Related]
34. The effects of disodium cromoglycate and beclomethasone dipropionate on the late nasal mucosa response to allergen challenge.
Pelikan Z
Ann Allergy; 1982 Oct; 49(4):200-12. PubMed ID: 6812468
[TBL] [Abstract][Full Text] [Related]
35. Levocabastine versus cromolyn sodium in the treatment of pollen-induced conjunctivitis.
Ciprandi G; Cerqueti PM; Sacca S; Cilli P; Canonica GW
Ann Allergy; 1990 Aug; 65(2):156-8. PubMed ID: 1974402
[TBL] [Abstract][Full Text] [Related]
36. Efficacy of levocabastine in conjunctival provocation studies.
Janssens M
Doc Ophthalmol; 1992; 82(4):341-51. PubMed ID: 1363980
[TBL] [Abstract][Full Text] [Related]
37. [Efficacy of levocabastine in perennial rhinitis].
Pacor ML; Biasi D; Maleknia T; Carletto A; Lunardi C
Clin Ter; 1996 Jun; 147(6):295-8. PubMed ID: 8925638
[TBL] [Abstract][Full Text] [Related]
38. Disodium cromoglycate (Lomudal) in the treatment of hay fever.
Illum P; Meistrup-Larsen U; Moesner J; Olesen K; Olsen SZ
Acta Allergol; 1973 Dec; 28(5):416-24. PubMed ID: 4150611
[No Abstract] [Full Text] [Related]
39. Evaluation of 0.05% levocabastine versus 4% sodium cromolyn in the allergen challenge model.
Abelson MB; George MA; Smith LM
Ophthalmology; 1995 Feb; 102(2):310-6. PubMed ID: 7862419
[TBL] [Abstract][Full Text] [Related]
40. Nasal provocation test using allergen extract versus cold dry air provocation test: which and when?
Kim YH; Jang TY
Am J Rhinol Allergy; 2013; 27(2):113-7. PubMed ID: 23562199
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
